首页> 外文期刊>Pathology Research and Practice >miR-425 regulates cell proliferation, migration and apoptosis by targeting AMPH-1 in non-small-cell lung cancer
【24h】

miR-425 regulates cell proliferation, migration and apoptosis by targeting AMPH-1 in non-small-cell lung cancer

机译:miR-425通过靶向非小细胞肺癌中的AMPH-1来调节细胞增殖,迁移和细胞凋亡

获取原文
获取原文并翻译 | 示例
       

摘要

Background: MicroRNAs (miRNAs) have been proved to act as vital roles on non-small-cell lung cancer (NSCLC), and miR-425 has been proven to serve an important function in several tumors. However, the functional role of miR-425 on NSCLC is still unclear. Methods: The mRNA and protein expression of miR-425 and AMPH-1 were determined by qRT-PCR and western blot analysis, respectively. NSCLC cells (SK-MES-1 and A549) proliferation and migration were measured by CCK-8 and transwell assay, respectively. Cell apoptosis was assessed by flow cytometry and western blotting, In addition, luciferase reporter assay was carried out to confirm the direct targeting of AMPH-1 by miR-425. Xenograft experiments were performed to observe the tumorigenesis of miR-425 in vivo. Results: The results showed that miR-425 was overexpressed and AMPH-1 expression was downregulated in SK-MES-1 and A549 cells. Silencing miR-425 inhibited proliferation, migration and promoted apoptosis of NSCLC cells. Moreover, we proved that miR-425 could target AMPH-1. The expression of AMPH-1was upregulated in A549 with miR-425 inhibitor. Moreover, miR-425 knockdown were less tumorigenic than the control in vivo. Conclusions: Taken together, miR-425 could promote the proliferation, invasion and suppress apoptosis by targeting AMPH-1 in NSCLC cells. miR-425/AMPH-1 axis may represent a potential therapeutic strategy or novel prognostic biomarkers to NSCLC.
机译:背景:已证明MicroRNA(MiRNA)作为非小细胞肺癌(NSCLC)的重要作用,并且已被证明在几种肿瘤中提供重要功能。然而,MIR-425对NSCLC的功能作用仍然不清楚。方法:通过QRT-PCR和Western印迹分析测定miR-425和AMPH-1的mRNA和蛋白表达。通过CCK-8和Transwell测定法测量NSCLC细胞(SK-MES-1和A549)的增殖和迁移。通过流式细胞术和Western印迹评估细胞凋亡,另外,进行荧光素酶报告结果以确认MIR-425的直接靶向AMPH-1。进行异种移植实验以观察体内miR-425的肿瘤鉴定。结果:结果表明,MIR-425过表达,AMPH-1表达在SK-MES-1和A549细胞中下调。沉默MiR-425抑制了NSCLC细胞的增殖,迁移和促进凋亡。此外,我们证明MIR-425可以针对AMPH-1。 AMPH-1的表达上调在A549中,MIR-425抑制剂。此外,MIR-425敲低的肿瘤率低于体内对照。结论:通过在NSCLC细胞中靶向AMPH-1,MiR-425携带MiR-425可以促进增殖,侵袭和抑制细胞凋亡。 miR-425 / amph-1轴可以代表NSCLC的潜在治疗策略或新型预后生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号